Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01993095
Other study ID # IL-0009
Secondary ID
Status Completed
Phase N/A
First received October 18, 2013
Last updated February 21, 2017
Start date October 2013
Est. completion date September 2014

Study information

Verified date February 2017
Source University of Illinois at Urbana-Champaign
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to test the effectiveness of a DVD-delivered, home-based six-month physical activity intervention for people with Multiple Sclerosis.


Description:

Persons with MS are less likely to be active than their healthy counterparts, a statistic that is compounded by the symptom manifestations of MS. However, there is increasing evidence to support the importance of physical activity in MS. Unfortunately, structured, safe, and efficacious physical activity programs that are often conducted in medical or university settings are often not accessible to many older adults with or without MS. We propose to conduct a randomized controlled pilot trial testing the efficacy of a DVD-delivered physical activity intervention which targets factors that have the potential to reduce disability in older adults with MS. This DVD-based intervention has been previously approved by the IRB at the University of Illinois for a similar study with low-active, community-dwelling older adults (IRB Protocol Number: 09765). This novel intervention provides systematic, programmatic activities with alternative versions of each exercise that allow individuals of all capabilities to complete the program successfully. It focuses on improving flexibility, strength, and balance and has been demonstrated to be feasible, well-accepted, and efficacious in a large sample of older adults without MS. Importantly, intervention resulted in clinically significant improvements in the Short Physical Performance Battery, reliable determinant of disability, institutionalization, morbidity, and mortality. If such an intervention was equally successful in older persons with MS, this could have considerable public health impact.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date September 2014
Est. primary completion date September 2014
Accepts healthy volunteers No
Gender All
Age group 50 Years and older
Eligibility Inclusion Criteria:

- being non-active, defined as reporting not engaging in regular activity (30 minutes accumulated per day) on more than two days of the week in the prior six months;

- aged 50 years and older;

- fluent in English;

- relapse-free in the last 30 days;

- ambulatory with minimal assistance(i.e., walk independently or with a single-point assistive walking device such as a cane);

- the provision of medical clearance for participation in a physical activity program by participants' physicians, along with a physician-confirmed diagnosis of MS (communication with physicians will be facilitated by research staff).

Exclusion Criteria:

- self-reported physical activity on a regular basis within the last six months (2 times or more per week);

- younger than 50 years of age;

- relapse in the last 30 days;

- no regular access to a television;

- no physician-confirmed diagnosis of multiple sclerosis;

- unable to successfully score above 21 (out of 39)on the Telephone Interview of Cognitive Status questionnaire (TICS-M).

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Home-based, DVD-delivered physical activity
Subjects will be participating in a home-based physical activity program that focuses on flexibility, toning and balance. Exercises will be progressive over the six-months and will highlight modifications for varying levels. This program will be delivered on 3 DVDs. Participants will be asked to exercise with the DVD at least three times per week.
Behavioral: Usual care/Wait list
Participants in this arm will receive a DVD that focuses on healthy aging topics but does not include physical activity. They will receive the FlexToBa DVD after the completion of the 6-month follow-up testing.

Locations

Country Name City State
United States University of Illinois at Urbana-Champaign Urbana Illinois

Sponsors (2)

Lead Sponsor Collaborator
University of Illinois at Urbana-Champaign National Multiple Sclerosis Society

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline to six-months in assessments of functional fitness of sedentary adults who have Multiple Sclerosis The measurements will include:
Short physical performance battery -- measures walking speed, ability to rise from a chair, and standing balance
Baseline and six months
Primary Change from baseline to six-months in assessments of functional fitness of sedentary adults who have MS Measurements will include:
Timed 20-foot walk test -- walk 25 feet as quickly as possible;
Baseline and six-months
Primary Change in assessments of functional fitness assessments in sedentary adults with MS Measurements will include:
6-minute walk test -- walk as much as possible (in terms of distance) for 6 minutes;
Baseline and six-months
Primary Change from baseline to six-months in assessments of functional fitness of sedentary adults with MS Measurements will include:
Grip strength -- using a dynamometer, participants will demonstrate isometric grip strength;
Baseline and six-months
Primary Change from baseline to six-months in assessments of functional fitness of sedentary adults who have MS Measurements will include:
Flexibility -- sit and reach (lower body flexibility) and back scratch test (upper body flexibility)
Baseline and six-months
Primary Change from baseline to six-months in assessments of functional fitness of sedentary adults with MS Measurements will include:
Upper body strength -- bicep curls consisting of lifting a light hand-weight as many times as possible in 30-seconds;
Baseline and six-months
Primary Change from baseline to six-months in assessments of functional fitness of sedentary adults who have MS Measurements will include:
Balance -- a timed (up to 30-seconds) unassisted one-leg stand test with eyes open on each leg.
Baseline and six-months
Primary Change from baseline to six-months in assessments of reported quality of life in people with MS The Leeds Multiple Sclerosis Quality of Life Scale will be used as a disease specific quality of life measure for people with MS. Baseline and six months
Primary Change from baseline to six-months in assessments of reported quality of life in people with MS The Satisfaction with Life Scale will be used to assess global life satisfaction and is sensitive enough to detect changes in participants' perceptions over the course of a clinical intervention. Baseline and six-months
Secondary Change from baseline to six-months in assessments of cognitive performance in sedentary adults with MS The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) battery, which will be administered to assess cognitive performance. Baseline and six months
Secondary Change from baseline to six-months in assessments of reported barriers self-efficacy in people with MS Participants' situation-specific self-confidence for physical activity will be assessed using The Barriers Self-Efficacy Scale, which taps subjects' perceived capabilities to exercise three times per week for 40 minutes over the next two months in the face of commonly identified barriers to participation. Baseline and six months
Secondary Changes in physical activity relating to specified exercise program in sedentary adults with MS Adherence to exercise program as documented by daily exercise logs. Baseline and six months
Secondary Objective changes in physical activity in sedentary adults with MS Objective assessment of physical activity via accelerometry over seven days time. Baseline and six months
Secondary Self-reported changes in physical activity in sedentary adults with MS Subjective assessment of physical activity via the Godin Leisure Time Exercise Questionnaire, which assesses frequency of involvement in strenuous, moderate and light activities. Baseline and six months
Secondary Change from baseline to six-months in assessments of reported gait self-efficacy in sedentary adults with MS Participants' situation-specific self-confidence for physical activity will be assessed using The Gait Self-Efficacy Scale, which will assess participants' beliefs in their capabilities to negotiate stairs and objects in their path. Baseline and six-months
Secondary Change from baseline to six-months in assessments of reported exercise self-efficacy in sedentary people with MS The Exercise Self-Efficacy Scale will assess participants' beliefs in their ability to continue exercising on a three time per week basis at moderate intensities for 40+ minutes per session in the future. Baseline and six-months
Secondary Change from baseline to six-months in assessments of reported self-efficacy of walking in sedentary people with MS Walking Self-Efficacy Scale for Duration will assess participants' beliefs in their physical capability to successfully complete incremental 5-minute intervals (up to 40 minutes)of walking at a moderately fast pace. Baseline and six-months
See also
  Status Clinical Trial Phase
Completed NCT05528666 - Risk Perception in Multiple Sclerosis
Completed NCT03608527 - Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis N/A
Recruiting NCT05532943 - Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis Phase 1/Phase 2
Completed NCT02486640 - Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
Completed NCT01324232 - Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Phase 2
Completed NCT04546698 - 5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
Active, not recruiting NCT04380220 - Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
Completed NCT02835677 - Integrating Caregiver Support Into MS Care N/A
Completed NCT03686826 - Feasibility and Reliability of Multimodal Evoked Potentials
Recruiting NCT05964829 - Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis N/A
Withdrawn NCT06021561 - Orofacial Pain in Multiple Sclerosis
Completed NCT03653585 - Cortical Lesions in Patients With Multiple Sclerosis
Recruiting NCT04798651 - Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis N/A
Active, not recruiting NCT05054140 - Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis Phase 2
Completed NCT05447143 - Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis N/A
Recruiting NCT06195644 - Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients Phase 1
Completed NCT04147052 - iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis N/A
Completed NCT03591809 - Combined Exercise Training in Patients With Multiple Sclerosis N/A
Completed NCT03594357 - Cognitive Functions in Patients With Multiple Sclerosis
Completed NCT02845635 - MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis